Related Articles
Patterns of loss of heterozygosity in breast carcinoma during neoadjuvant chemotherapy
Distinct expression of Survivin splice variants in breast carcinomas
Study on the infusion‑site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant
Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer.